医学
腺癌
肺癌
比例危险模型
癌症
全肺切除术
肿瘤科
外科
内科学
癌
作者
Vignesh Raman,Oliver K. Jawitz,Soraya L. Voigt,Kristen Elizabeth Rhodin,Thomas Anthony D’Amico,David H. Harpole,Chi‐Fu Jeffrey Yang,Betty Caroline Tong
出处
期刊:Chest
[Elsevier BV]
日期:2020-07-08
卷期号:159 (1): 390-400
被引量:48
标识
DOI:10.1016/j.chest.2020.06.066
摘要
Background The interaction between tumor size and the comparative prognosis of lobar and sublobar resection has been defined poorly. Research Question The purpose of this study was to characterize the relationship between tumor size and the receipt of segmentectomy or lobectomy in association with overall survival in patients with clinically node-negative non-small cell lung cancer (NSCLC). Study Design and Methods The 2004-2015 National Cancer Database (NCDB) was queried for patients with cT1-3N0M0 NSCLC who underwent segmentectomy or lobectomy without neoadjuvant therapy or missing survival data. The primary outcome was overall survival, which was evaluated using multivariate Cox proportional hazards including an interaction term between tumor size and type of surgery. Results A total of 143,040 patients were included: 135,446 (95%) underwent lobectomy and 7594 (5%) underwent segmentectomy. In multivariate Cox regression, a significant three-way interaction was found among tumor size, histologic results, and type of surgery (P Interpretation In this NCDB study of patients with node-negative NSCLC, we found different tumor size thresholds, based on histologic results, that identified populations of patients who least and most benefitted from lobectomy compared with segmentectomy.
科研通智能强力驱动
Strongly Powered by AbleSci AI